Results

Total Results: 1,524 records

Showing results for "drugs".

421. Medication-Therapy-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
     November 01, 2014 - require multiple chronic conditions or a minimum number or level of expenditures on prescription drugs … following 3 elements: – Comprehensive medication review covering all prescription and nonprescription drugs … Proximal and intermediate outcomes included number of drugs, identification of drug therapy problems … Drugs. 2009;69(4):393-406. Epub: 2009/03/28. PMID: 19323584. 10. 108th U.S. Congress.

422. Monitoring-Programs-Rapid-Research-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
     October 08, 2025 - and transportation which includes: a) Consolidated Services Center for management and distribution of pharmaceuticals

423. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
     January 01, 2011 - Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Slide 1 Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) Maarten J…

424. CER 225: Evidence Summary Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
     May 01, 2020 - enrolled some combination of adolescents with mixed use of alcohol, cannabis, and occasionally other drugs

425. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-computerized-cds-protocol.pdf
     May 08, 2023 - EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review 1 Evidence-based Practice Center Rapid Review Protocol Project Title: Making Healthcare Safer IV: Computerized Clinical Decision Support to Prevent Medication Errors and Adverse Drug Events Review …

426. A Framework for Conceptualizing Evidence Needs of Health Systems (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
     December 01, 2017 - Decisions and questions for which health systems seek evidence • Technology (e.g., drugs, devices, products … and use of evidence in health systems focuses on the acquisition of health care technology (i.e., drugs … required evidence.18, 19 In one study, the most common technologies reviewed by HTA programs were drugs … 19% Policy 18% Non-drug, non- device intervention 14% Devices 12% Test, scales, risk factors 8% Drugs … Penn CEP FY2006- 2016 58% Rapid Review (2) 33% Clinical departments 17% CMO 21% Drugs

427. Making Healthcare Safer IV: Supply Chain Disruption Monitoring Programs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-protocol.pdf
     January 01, 2024 - effective are patient safety practices (PSPs) for identifying and monitoring critical supplies and drugs … and Economic Security (CARES) Act, established in 2020, which required manufacturers of certain drugs

428. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
     October 08, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

429. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
     January 01, 2018 - We searched Drugs@FDA for Medical/ Clinical and Statistical review documents containing harm data for … Results are presented in terms of a placebo referent, to rank the drugs based on a common comparator … SGAs Versus SGAs: Comparison of Different Drugs Sixteen (5 long-term) and 37 (13 long-term) studies … Consensus development conference on antipsychotic drugs and obesity and diabetes. … Pediatr Drugs. 2016;18: 319-328. PMID: 27278054. 38. Yoon Y, Wink LK, Pedapati EV, et al.

430. Revised Protocol - Opioids 12 13 13[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
     December 19, 2013 - http://www.fda.gov/downloads/Drugs/DrugSafet y/InformationbyDrugClass/UCM348818.pdf. 29. … www.effectivehealthcare.ahrq.gov http://www.uspreventiveservicestaskforce.org/us http://www.fda.gov/downloads/Drugs

431. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
     January 01, 2013 - The NDC is a unique, 10-digit, 3-segment number that is a standard product identifier for human drugs … Claims submitted to insurance companies for payment for drugs are submitted with the NDC number and information … Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly

432. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
     January 01, 2013 - exposures of interest are these two treatments, but it is also important to measure exposure to other drugs … such as aspirin or nonsteroidal anti-inflammatory drugs, which could increase the risk of GI bleeds … accurate than the recall of the use of medications (previous use of nonsteroidal anti-inflammatory drugs

433. women-hiv-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
     March 01, 2016 - rates of substance abuse compared to younger women, they may be more vulnerable to the effects of drugs … depression, PTSD, bipolar, schizophrenia), addiction and substance abuse (heroin, cocaine, prescription drugs … , alcohol, smoking, “party” drugs such as MDMA [Ecstasy], Flunitrazepam [Rohypnol], Ketamine), musculoskeletal

434. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - The ERT manufacturers’ websites will be searched to inform Guiding Questions 1 and 2: Biomarin Pharmaceuticals … Emerging drugs for lysosomal storage diseases. Expert Opin Emerg Drugs 2010 Sep;15(3):495-507. … Inc (March 2010) Zavesca® (miglustat), Actelion Pharmaceuticals, FDA approved in Aug 2003 for adult

435. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists five topics for which (1) preliminary phase III data for drugs were … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.

436. Making Healthcare Safer IV: Summary of Findings, 2023-2024 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
     May 01, 2024 - available at: https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk- drugs-rapid-response.pdf … https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf … https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf

437. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
     January 01, 2023 - J Stud Alcohol Drugs. 2008 Jul;69(4):535-8. PMID: 18612569. 24. … https://go.drugbank.com/drugs/DB00659. Accessed on March 22, 2022. 36. … https://go.drugbank.com/drugs/DB00822. Accessed on March 22, 2022. 38. … /effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research https://go.drugbank.com/drugs … tab=summary&ligandId=7106 https://go.drugbank.com/drugs/DB00822 42.

438. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - How about treatment duration in these drugs? … We have commented on the imprecision for several drugs due to small samples, and have run an adjusted … We had mentioned the limited precision from several drugs. … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.) … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.)

439. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - How about treatment duration in these drugs? … We have commented on the imprecision for several drugs due to small samples, and have run an adjusted … We had mentioned the limited precision from several drugs. … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.) … Public Comment (Cynthia Russo, Janssen Pharmaceuticals, Inc.)

440. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
     January 01, 2009 - especially true in diseases that afflict patients with lower compliance rates such as abusers of alcohol and drugs … evaluating magnesium as a treatment for acute myocardial infarction that were conducted before thrombolytic drugs … , antiplatelet drugs, ß-blockers, and primary percutaneous coronary intervention (PCI) were used Only … as an outcome measure Trials comparing cyclooxygenase-2 inhibitors and nonsteroidal antiinflammatory drugs